You can often spot it in the mirror on a bright Melbourne morning – that under-eye hollow that makes you look tired even after a solid night’s sleep. But the tear trough area is unforgiving: a small change can look beautifully refreshed, or slightly off. That’s why a tear trough filler suitability assessment matters. It’s less about whether filler exists as an option, and more about whether it’s the right option for your face, your skin, and your tolerance for risk and maintenance.
What the tear trough actually is (and why it’s tricky)
The tear trough is the groove that runs from the inner corner of the eye along the lower eyelid-cheek junction. For some people it’s genetic and present from early adulthood. For others it becomes more obvious as facial volume shifts over time and the mid-face changes.
This area is complex. Skin is thinner, lymphatic drainage is easily disrupted, and the transition between eyelid and cheek can show shadows quickly. Under-eye concerns can also be caused by pigmentation, puffiness, or skin laxity rather than true volume loss. A good assessment separates these, because treating the wrong “cause” with the wrong approach is how under-eye results become disappointing.
What a tear trough filler suitability assessment is designed to decide
A proper suitability assessment is a clinical decision-making process. It aims to confirm what’s driving your under-eye appearance and whether dermal filler is likely to create a refined improvement with an acceptable risk profile.
In practice, your clinician is weighing three things at the same time: the aesthetic goal (what you want to see), the anatomy (what your tissues will allow), and the safety considerations (what your individual risk factors are).
The under-eye concerns that may respond well
Under-eye filler can be considered when the primary issue is a hollow or shadow created by a true volume deficit at the lid-cheek junction. The best candidates tend to have a defined depression rather than prominent swelling.
It can also be suitable when the transition from the lower lid into the upper cheek lacks support, particularly where subtle mid-face volume changes are contributing to shadowing. In these cases, a clinician may discuss whether cheek support, tear trough treatment, or a combined approach is more appropriate – the most polished results often come from treating the structure, not chasing the shadow.
When tear trough filler may not be the right choice
A sophisticated plan includes knowing when not to place filler under the eyes. If your concern is primarily puffiness or “bags”, adding volume can worsen the appearance. If the area retains fluid easily, filler may increase the chance of lingering swelling.
If dark circles are mainly due to pigmentation or visible blood vessels through thin skin, filler may not meaningfully change colour – and can sometimes make the area look heavier. If there is significant skin laxity or crepey texture, the issue may be skin quality rather than volume, and different modalities may be more suitable.
This is where a consultation becomes valuable: it protects you from spending on a treatment that isn’t aligned with what your under-eye area actually needs.
What your clinician assesses in the mirror and under clinic lighting
A tear trough filler suitability assessment is detail-driven. Expect your clinician to look at your under-eye area from multiple angles, in different lighting, and with gentle palpation (touch) to understand the tissue.
They will assess skin thickness and quality, the depth and shape of the hollow, and how the eyelid-cheek junction behaves when you smile. They’ll also check whether shadowing improves when the cheek is supported, which can indicate that mid-face support is part of the solution.
They will look for signs of fluid retention, as well as how prominent any lower lid fat pads are. These factors influence not only whether filler is suitable, but also how conservative the plan needs to be.
Your medical history matters more than most people expect
Suitability is not just aesthetic. Your clinician should ask about your general health, past cosmetic treatments, medications and supplements, allergies, and whether you have a history of swelling or sensitivity around the eyes.
Previous under-eye filler is particularly relevant. If product is still present, or if there has been prolonged puffiness in the past, this changes the risk profile and may change the recommendation.
A transparent conversation here supports better outcomes. The goal is a refined result that fits your face – and a treatment plan you feel comfortable maintaining.
The “natural result” question: what you can realistically expect
Under-eye filler is not meant to erase every line or change your eye shape. The most elegant outcomes are subtle: a softened hollow, a smoother transition into the cheek, and a more rested look.
Because the area is delicate, clinicians generally aim for conservative correction rather than maximum volume. In many cases, less is genuinely more. A suitability assessment should include a discussion about what “improvement” looks like for you, and whether your expectations match what the anatomy can deliver.
If your goal is a dramatic transformation, your clinician may recommend a different pathway – or may recommend against treatment altogether.
Risks and trade-offs to consider before proceeding
All cosmetic injectable procedures carry risk, and the under-eye area is considered technically demanding. A high-quality assessment includes a clear discussion of potential side effects and complications, tailored to your individual risk factors.
Common temporary effects can include swelling, tenderness and bruising. Some people experience prolonged puffiness, particularly if they are prone to fluid retention. Irregularities, asymmetry, or a visible “overfilled” look can occur if too much product is used or if the product sits too superficially.
Another trade-off is maintenance. Tear trough results can vary in longevity and may change as your face changes. Your clinician should discuss whether you prefer a treatment you can maintain quietly and periodically, or whether you would rather focus on skin quality and prevention.
What a consultation-led plan can look like
A refined under-eye plan is rarely a single decision made in isolation. Depending on what the assessment finds, your clinician may discuss options such as addressing cheek support first, focusing on skin health, or spacing treatment across sessions for a more controlled result.
This approach suits clients who want elegance over drama. It also aligns with the reality that under-eye rejuvenation is as much about balance as it is about volume.
At Core Aesthetics, the pathway is consultation-first, so suitability and a tailored plan are established before any treatment is considered.
How to prepare for your suitability assessment
Come in with a clear sense of what bothers you most – is it the hollow, the shadow, the puffiness, or the colour? If possible, bring a couple of makeup-free photos taken in natural light where you feel the under-eye area looks most noticeable. This helps your clinician understand what you’re seeing day to day.
Arrive ready to talk through your history, including any previous treatments in the area. If you are prone to swelling, mention it. If you have an important event coming up, flag your timing preferences early so you can plan conservatively.
The question that decides everything
If you take one thing from a tear trough filler suitability assessment, let it be this: the best treatment is the one that suits your anatomy, not the one that suits the trend.
A rested, polished under-eye result is achievable for the right candidate, with the right plan and the right level of restraint. If your assessment suggests filler is not your best option, that is still a win – it means you’re being guided towards an approach that respects your face and prioritises refined outcomes.
General Information Only
This article is general in nature and does not replace a consultation with a qualified health practitioner. Treatment outcomes, suitability and risks vary by individual. Any medical or prescription treatment options can only be discussed and provided where clinically appropriate following an individual assessment.
